Product Information

EVEROLIMUS 0.5 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $2.9773 per EA under NDC 67877071931. Its NADAC has been published 205 times since Dec 21, 2022.

FDA first approved this application on Nov 26, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EVEROLIMUS 0.5 MG TABLET

Everolimus
$2.9773per EA

Strength

.5 mg/1

NDC

67877071931

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

EVEROLIMUS

Approval Type

Generic (ANDA)

FDA Application

ANDA214138

FDA Approved

11/26/2021

TE Code

AB

On Market Since

11/27/2021

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors

Price Statistics

The NADAC for EVEROLIMUS 0.5 MG TABLET has been published 205 times since Dec 21, 2022, and over the history we have for it it has declined 76.3%. The table below summarizes its recorded NADAC range and movement.

Current price$2.9773 per EA
All-time high$12.5530 (Mar 15, 2023)
All-time low$2.9773 (Nov 18, 2026)
52-week high$4.2997
52-week low$2.9773
Median price$4.8878
Average price$5.5058
Largest weekly change-59.6% (Mar 22, 2023)
Weeks tracked205
Tracking sinceDec 21, 2022

Price History

1W

-7.0%

1M

-15.5%

3M

-20.7%

6M

-17.4%

1Y

-32.3%

3Y

-50.8%

5Y

N/A

All

-76.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EVEROLIMUS 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 0.5 MG TABLET, manufactured by Ascend Laboratories, LLC, is $2.9773 per EA (NDC 67877071931), effective Nov 18, 2026.

How has the price of EVEROLIMUS 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for EVEROLIMUS 0.5 MG TABLET has declined 76.3%. It has been tracked across 205 weekly CMS publications since Dec 21, 2022.

What are the highest and lowest recorded NADAC prices for EVEROLIMUS 0.5 MG TABLET?

Since Dec 21, 2022, the NADAC for EVEROLIMUS 0.5 MG TABLET has ranged from a low of $2.9773 (Nov 18, 2026) to a high of $12.5530 (Mar 15, 2023), with a median of $4.8878 per EA.

Are there cheaper alternatives to EVEROLIMUS 0.5 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as EVEROLIMUS 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures EVEROLIMUS 0.5 MG TABLET?

EVEROLIMUS 0.5 MG TABLET (NDC 67877071931) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.